These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6777029)
41. [Automutilation after consumption of hallucinogenic mushrooms]. Attema-de Jonge ME; Portier CB; Franssen EJ Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2869-72. PubMed ID: 18257429 [TBL] [Abstract][Full Text] [Related]
42. Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin. Sherwood AM; Halberstadt AL; Klein AK; McCorvy JD; Kaylo KW; Kargbo RB; Meisenheimer P J Nat Prod; 2020 Feb; 83(2):461-467. PubMed ID: 32077284 [TBL] [Abstract][Full Text] [Related]
43. Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects. Kaplan J; Mandel LR; Stillman R; Walker RW; VandenHeuvel WJ; Gillin JC; Wyatt RJ Psychopharmacologia; 1974; 38(3):239-45. PubMed ID: 4607811 [No Abstract] [Full Text] [Related]
44. [History of the discovery of Mexican hallucinogenic mushroooms] (Fr). Heim R Colloq Int CNRS; 1966; (144):243-62. PubMed ID: 11624144 [No Abstract] [Full Text] [Related]
45. [Old and new investigations on hallucinogenic mushrooms from Mexico, on their action and on the substances which are responsible for their action]. HEIM R Actual Pharmacol (Paris); 1959; 12():171-92. PubMed ID: 14400658 [No Abstract] [Full Text] [Related]
46. Mannitol in Amanita muscaria--an osmotic blood-brain barrier disruptor enhancing its hallucinogenic action? Maciejczyk E; Kafarski P Med Hypotheses; 2013 Nov; 81(5):766-7. PubMed ID: 23932733 [TBL] [Abstract][Full Text] [Related]
49. Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis. Leung AY; Paul AG J Pharm Sci; 1968 Oct; 57(10):1667-71. PubMed ID: 5684732 [No Abstract] [Full Text] [Related]
50. A review of nicotinic acid, N-methylated indoleamines and schizophrenia. Luchins D; Ban TA; Lehmann HE Int Pharmacopsychiatry; 1978; 13(1):16-33. PubMed ID: 342436 [TBL] [Abstract][Full Text] [Related]
52. Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Winstock AR; Kaar S; Borschmann R J Psychopharmacol; 2014 Jan; 28(1):49-54. PubMed ID: 24284475 [TBL] [Abstract][Full Text] [Related]